Validation of a novel ELISA-based VASP whole blood assay to measure P2Y12-ADP receptor activity

被引：13

作者：

Barragan, Paul ^{[1
]}

Paganelli, Franck ^{[2
]}

Camoin-Jau, Laurence ^{[3
,4
]}

Bourguet, Nicolas ^{[5
]}

Boulay-Moine, Daniele ^{[5
]}

Moulard, Maxime ^{[5
]}

Bonello, Laurent ^{[2
,3
]}

机构：

[1] Clin Fleurs, Dept Cardiol, Ollioules, France

[2] Hop Univ Nord, Dept Cardiol, Marseille, France

[3] Hop Conception, Hematol Lab, Marseille, France

[4] Fac Pharm Marseille, INSERM, UMRS 608, Marseille, France

[5] BioCytex, Biomarkers, Marseille, France

来源：

THROMBOSIS AND HAEMOSTASIS | 2010年 / 104卷 / 02期

关键词：

VASODILATOR-STIMULATED PHOSPHOPROTEIN; PERCUTANEOUS CORONARY INTERVENTION; ADVERSE CARDIOVASCULAR EVENTS; FLOW-CYTOMETRIC ANALYSIS; CLOPIDOGREL RESISTANCE; PLATELET-AGGREGATION; STENT THROMBOSIS; PHOSPHORYLATION; INHIBITION; THERAPY;

D O I：

10.1160/TH10-02-0086

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：410 / 411

页数：2

共 15 条

[1] Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases [J].

Aleil, B ;

Ravanat, C ;

Cazenave, JP ;

Rochoux, G ;

Heitz, A ;

Gachet, C .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (01) :85-92

[2] Resistance to thienopyridines: Clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation [J].

Barragan, P ;

Bouvier, JL ;

Roquebert, PO ;

Macaluso, G ;

Commeau, P ;

Comet, B ;

Lafont, A ;

Camoin, L ;

Walter, U ;

Eigenthaler, M .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2003, 59 (03) :295-302

[3] The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis [J].

Blindt, Ruediger ;

Stellbrink, Katja ;

de Taeye, Anita ;

Mueller, Robert ;

Kiefer, Paul ;

Yagmur, Eray ;

Weber, Christian ;

Kelm, Malte ;

Hoffmann, Rainer .

THROMBOSIS AND HAEMOSTASIS, 2007, 98 (06) :1329-1334

[4] Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events [J].

Bonello, L. ;

Paganelli, F. ;

Arpin-Bornet, M. ;

Auquier, P. ;

Sampol, J. ;

Dignat-George, F. ;

Barragan, P. ;

Camoin-Jau, L. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (08) :1630-1636

[5] Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: A multicenter randomized prospective study [J].

Bonello, Laurent ;

Camoin-Jau, Laurence ;

Arques, Stephane ;

Boyer, Christian ;

Panagides, Dimitri ;

Wittenberg, Olivier ;

Simeoni, Marie-Claude ;

Barragan, Paul ;

Dignat-George, Francoise ;

Paganelli, Franck .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (14) :1404-1411

[6] Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Acute and Subacute Stent Thrombosis [J].

Bonello, Laurent ;

Camoin-Jau, Laurence ;

Armero, Sebastien ;

Com, Olivier ;

Arques, Stephane ;

Burignat-Bonello, Caroline ;

Giacomoni, Marie-Paule ;

Bonello, Roland ;

Collet, Frederic ;

Rossi, Philippe ;

Barragan, Paul ;

Dignat-George, Francoise ;

Paganelli, Franck .

AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (01) :5-10

[7] ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome [J].

Frere, Corinne ;

Cuisset, Thomas ;

Quilici, Jacques ;

Camoin, Laurence ;

Carvajal, Joseph ;

Morange, Pierre Emmanuel ;

Lambert, Marc ;

Juhan-Vague, Irene ;

Bonnet, Jean-Louis ;

Alessi, Marie-Christine .

THROMBOSIS AND HAEMOSTASIS, 2007, 98 (04) :838-843

[8] Monitoring of clopidogrel action: Comparison of methods [J].

Geiger, J ;

Teichmann, L ;

Grossmann, R ;

Aktas, B ;

Steigerwald, U ;

Walter, U ;

Schinzel, R .

CLINICAL CHEMISTRY, 2005, 51 (06) :957-965

[9] Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction [J].

Matetzky, S ;

Shenkman, B ;

Guetta, V ;

Schechter, M ;

Bienart, R ;

Goldenberg, I ;

Novikov, I ;

Pres, H ;

Savion, N ;

Varon, D ;

Hod, H .

CIRCULATION, 2004, 109 (25) :3171-3175

[10] Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study [J].

Mehta, SR ;

Yusuf, S ;

Peters, RJG ;

Bertrand, ME ;

Lewis, BS ;

Natarajan, MK ;

Maimberg, K ;

Rupprecht, HJ ;

Zhao, F ;

Chrolavicius, S ;

Copland, I ;

Fox, KAA .

LANCET, 2001, 358 (9281) :527-533

← 1 2 →